Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1982 1
1994 1
1995 1
1997 1
1998 2
2002 1
2003 2
2004 3
2005 1
2007 2
2008 1
2009 1
2010 3
2011 2
2012 5
2013 5
2014 1
2015 2
2016 5
2017 2
2018 1
2019 6
2020 6
2021 1
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Invasive Bladder Mixed Carcinoma"
Page 1
Nephrogenic adenoma of the urinary tract: A 6-year single center experience.
Turcan D, Acikalin MF, Yilmaz E, Canaz F, Arik D. Turcan D, et al. Pathol Res Pract. 2017 Jul;213(7):831-835. doi: 10.1016/j.prp.2017.03.001. Epub 2017 Mar 25. Pathol Res Pract. 2017. PMID: 28554748 Review.
BACKGROUND: Nephrogenic adenoma is an uncommon benign lesion that occurs at several sites in urinary tract, from the renal pelvis to urethra, with the highest frequency in urinary bladder. ...A history of urothelial carcinoma and repeated TUR procedure …
BACKGROUND: Nephrogenic adenoma is an uncommon benign lesion that occurs at several sites in urinary tract, from the renal pelvis to …
Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
Paner GP, Lopez-Beltran A, Sirohi D, Amin MB. Paner GP, et al. Adv Anat Pathol. 2016 Mar;23(2):71-83. doi: 10.1097/PAP.0000000000000110. Adv Anat Pathol. 2016. PMID: 26849813 Review.
For noncystic (usual) invasive adenocarcinomas, the traditionally described histologic subtypes of enteric, mucinous, signet ring cell, not otherwise specified, and mixed remain appropriate, with 50% of tumors classified as mucinous subtype. ...Rare nonglandular mor …
For noncystic (usual) invasive adenocarcinomas, the traditionally described histologic subtypes of enteric, mucinous, signet ring cel …
Fluid intake and clinicopathological characteristics of bladder cancer: the West Midlands Bladder Cancer Prognosis Programme.
van Hensbergen M, van Osch FHM, Jochems S, James ND, Wallace DMA, Wesselius A, Cheng KK, Bryan RT, Zeegers MP. van Hensbergen M, et al. Eur J Cancer Prev. 2020 Mar;29(2):110-118. doi: 10.1097/CEJ.0000000000000525. Eur J Cancer Prev. 2020. PMID: 32012137
OBJECTIVE: Between 10 and 20% of bladder cancer patients who are diagnosed with nonmuscle-invasive bladder cancer will progress to muscle-invasive disease. ...RESULTS: Age at diagnosis was distributed differently amongst those in different total fluid …
OBJECTIVE: Between 10 and 20% of bladder cancer patients who are diagnosed with nonmuscle-invasive bladder cancer will …
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.
Derré L, Lucca I, Cesson V, Bohner P, Crettenand F, Rodrigues-Dias SC, Dartiguenave F, Masnada A, Teixeira-Pereira C, Benmerzoug S, Chevalier MF, Domingos-Pereira S, Nguyen S, Polak L, Schneider AK, Jichlinski P, Roth B, Nardelli-Haefliger D. Derré L, et al. J Immunother Cancer. 2023 Dec 14;11(12):e008020. doi: 10.1136/jitc-2023-008020. J Immunother Cancer. 2023. PMID: 38101861 Free PMC article.
RESULTS: As compared with BCG, Ty21a induced lower levels of inflammatory urinary cytokines, which correlated to the milder adverse events (AEs) observed in Ty21a patients. ...Peripheral Ty21a-specific T-cell responses and/or antibodies were observed in most …
RESULTS: As compared with BCG, Ty21a induced lower levels of inflammatory urinary cytokines, which correlated to the milder adverse e …
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer.
Garczyk S, Degener S, Bischoff F, Schnitzler T, Salz A, Golz R, Buchner A, Schulz GB, Schneider U, Gaisa NT, Knüchel R. Garczyk S, et al. Virchows Arch. 2022 Jul;481(1):83-92. doi: 10.1007/s00428-022-03328-1. Epub 2022 Apr 28. Virchows Arch. 2022. PMID: 35484425 Free PMC article.
High-grade non-muscle-invasive bladder cancer (HG NMIBC) patients are at high risk (HR) of progression to muscle-invasion. ...Moreover, higher NECTIN4 heterogeneity was observed in patients with multifocal mixed TaHG tumors (22% of patients) com …
High-grade non-muscle-invasive bladder cancer (HG NMIBC) patients are at high risk (HR) of progression to muscle-invasion …
Health-related Quality of Life After Robotic-assisted vs Open Radical Cystectomy: Analysis of a Randomized Trial.
Clements MB, Beech BB, Atkinson TM, Dalbagni GM, Li Y, Vickers AJ, Herr HW, Donat SM, Sjoberg DD, Tin AL, Coleman JA, Rapkin BD, Laudone VP, Bochner BH. Clements MB, et al. J Urol. 2023 May;209(5):901-910. doi: 10.1097/JU.0000000000003201. Epub 2023 Feb 1. J Urol. 2023. PMID: 36724053 Free PMC article. Clinical Trial.
The prospective health-related quality of life study collected 14 patient-reported outcomes measures preoperatively and at 3, 6, 12, 18, and 24 months postoperatively. Linear mixed-effects models with an interaction term (study armtime) were used to test for differences in …
The prospective health-related quality of life study collected 14 patient-reported outcomes measures preoperatively and at 3, 6, 12, 18, and …
Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial.
Witjes JA, Galsky MD, Gschwend JE, Broughton E, Braverman J, Nasroulah F, Maira-Arce M, Ye X, Shi L, Guo S, Hamilton M, Bajorin DF. Witjes JA, et al. Eur Urol Oncol. 2022 Oct;5(5):553-563. doi: 10.1016/j.euo.2022.02.003. Epub 2022 Mar 11. Eur Urol Oncol. 2022. PMID: 35288066 Free PMC article. Clinical Trial.
BACKGROUND: The programmed death-1 (PD-1) inhibitor nivolumab prolongs disease-free survival in patients with muscle-invasive urothelial carcinoma (MIUC). OBJECTIVE: To evaluate the effects of nivolumab on health-related quality of life (HRQoL) after radical resecti …
BACKGROUND: The programmed death-1 (PD-1) inhibitor nivolumab prolongs disease-free survival in patients with muscle-invasive urothel …
Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Paner GP, Barkan GA, Mehta V, Sirintrapun SJ, Tsuzuki T, Sebo TJ, Jimenez RE. Paner GP, et al. Am J Surg Pathol. 2012 Mar;36(3):432-42. doi: 10.1097/PAS.0b013e31823fe49c. Am J Surg Pathol. 2012. PMID: 22301493 Review.
Histologically, 5 were urothelial carcinomas, of pure or mixed histology, all were high grade and invasive, and 2 were small cell carcinomas. ...These tumors may arise as deep-seated bladder-related or completely supravesical tumors along the ur …
Histologically, 5 were urothelial carcinomas, of pure or mixed histology, all were high grade and invasive, and 2 were …
Clinicopathologic features and prognostic significance of mixed (Low and high-grade) papillary urothelial carcinoma comparison with low and high-grade papillary urothelial carcinoma.
Kir G, Cecikoglu GE, Topal CS, Sorkun MH, Culpan M, Suceken FY, Karaca H, Yildirim A. Kir G, et al. Virchows Arch. 2023 Nov;483(5):621-634. doi: 10.1007/s00428-023-03625-3. Epub 2023 Aug 26. Virchows Arch. 2023. PMID: 37632533
According to this classification, a lesion is classified as mixed-grade (MG) if the highest-grade component comprises less than 5% high-grade (HG) carcinoma [14]. ...In addition, 160 consecutive and unselected cases of MG papillary urothelial carcinoma (MGUC) …
According to this classification, a lesion is classified as mixed-grade (MG) if the highest-grade component comprises less than 5% hi …
Carcinoma In Situ of the Urinary Bladder: A Systematic Review of Current Knowledge Regarding Detection, Treatment, and Outcomes.
Subiela JD, Rodríguez Faba O, Guerrero Ramos F, Vila Reyes H, Pisano F, Breda A, Palou J. Subiela JD, et al. Eur Urol Focus. 2020 Jul 15;6(4):674-682. doi: 10.1016/j.euf.2019.03.012. Epub 2019 Mar 23. Eur Urol Focus. 2020. PMID: 30910393
CONTEXT: Carcinoma in situ (CIS) of the bladder is defined as a high-grade flat lesion confined to the mucosa. ...EVIDENCE SYNTHESIS: Overall 62 articles met the inclusion criteria. Most articles concerned retrospective studies and presented mixed data with o …
CONTEXT: Carcinoma in situ (CIS) of the bladder is defined as a high-grade flat lesion confined to the mucosa. ...EVIDENCE SYN …
56 results